NPR: Temperature control in medicine delivery a rising risk

Consumers are used to getting what they need easily with the click of a button, including ordering and receiving their prescription medications through the mail. But those deliveries may be risky if medicines aren't stored and transported carefully, according to a report from NPR. 

Important medications are sometimes left outside of homes in the delivery process, exposing drugs to varying temperatures. For some patients, those actions can have consequences by impacting the effectiveness of a prescription.

In one such case in Arizona, a box of anti-rejection medications for a young boy, who had a liver transplant, was left outside the family’s garage for hours on a day when temperatures soared above 100 degrees, “well beyond the safe temperature range listed on the drug's guidelines,” NPR reported.

Shortly after, the boy’s body appeared to be rejecting the new organ, and the setback was enough for his mother to swear off mail-order pharmacy forever.

Despite the experiences shared by some consumers, online pharmacies maintain they provide temperature-controlled shipping and follow all FDA rules. Mail-order drugs are also a huge money-saver for pharmacy benefit managers, but scientists aren’t really sure how medicines are impacted by extreme temperatures, according to NPR.

The issue is getting attention as medicine delivery is becoming more widespread. E-commerce giant Amazon acquired online pharmacy PillPack in mid-2018 for approximately $1 billion. The prevalence of mail-order drugs could lead to expanded temperature control measures among pharmacies.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.